Benitec Biopharma Files 8-K
Ticker: BNTC · Form: 8-K · Filed: Mar 28, 2025 · CIK: 1808898
| Field | Detail |
|---|---|
| Company | Benitec Biopharma INC. (BNTC) |
| Form Type | 8-K |
| Filed Date | Mar 28, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing
TL;DR
Benitec Biopharma filed an 8-K for an 'Other Event' on 3/26/25. Details pending.
AI Summary
On March 26, 2025, Benitec Biopharma Inc. filed an 8-K report. The filing indicates an 'Other Event' without specifying further details in the provided text. The company is incorporated in Delaware and headquartered in Hayward, California.
Why It Matters
This filing signals a material event for Benitec Biopharma Inc., requiring disclosure to investors. The specific nature of the 'Other Event' will be crucial for understanding its impact.
Risk Assessment
Risk Level: medium — The filing indicates a material event, but the lack of specific details in the provided text creates uncertainty about the associated risks.
Key Players & Entities
- Benitec Biopharma Inc. (company) — Registrant
- March 26, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Hayward, California (location) — Principal Executive Offices
- 001-39267 (identifier) — Commission File Number
FAQ
What specific 'Other Event' is reported in this 8-K filing by Benitec Biopharma Inc.?
The provided text of the 8-K filing states 'Other Events' as the item information but does not specify the nature of the event.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on March 26, 2025.
What is Benitec Biopharma Inc.'s principal executive office address?
Benitec Biopharma Inc.'s principal executive offices are located at 3940 Trust Way, Hayward, California, 94545.
What is Benitec Biopharma Inc.'s Commission File Number?
Benitec Biopharma Inc.'s Commission File Number is 001-39267.
In which state is Benitec Biopharma Inc. incorporated?
Benitec Biopharma Inc. is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 28, 2025 regarding Benitec Biopharma Inc. (BNTC).